Genetic markers in the diagnosis of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 3, Issue 3, 2001, Pages 293-304

  Rogaeva, E ^a   Tandon, A ^a   St George Hyslop, P H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; ARTICLE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MARKER; GENETIC SUSCEPTIBILITY; HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0034977793     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2001-3304     Document Type: Article

References (172)

1. The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region
2. Presenilin 1 protein directly interacts with bcl-2
3. Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 - Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease
4. Presenilin 1 controls gammasecretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons
5. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition
6. Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing
7. Expression analysis of BACE2 in brain and peripheral tissues
8. A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's {beta}-secretase
9. Wide range in age of onset for chromosome 1 - Related familial Alzheimer's disease
10. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abetal-42/1-40 ratio in vitro and in vivo
11. Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease
12. Caspase-mediated cleavage is not required for the activity of presenilins in amyloidogenesis and NOTCH signaling
13. Calsenilin: A calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment
14. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex
15. Presenilin-1 differentially facilitates endoproteolysis of the beta-amyloid precursor protein and Notch
16. Maturation and Pro-peptide Cleavage of beta-Secretase
17. More missense in amyloid gene
18. Apolipoprotein E promoter and alpha2-macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer's disease
19. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production
20. Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation
21. Mutant presenilins of Alzheimer's disease increase production of 42- residue amyloid beta-protein in both transfected cells and transgenic mice
22. Notch 1 is required for the coordinate segmentation of somites
23. Multi-locus linkage tests based on affected relative pairs
24. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
25. The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations
26. The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a case-control sample
27. A polymorphism in the cystatin C gene is a novel risk factor for late- onset Alzheimer's disease
28. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease
29. Association between Alzheimer's disease and the NOS3 gene
30. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain
31. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
32. Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PCl2 cells
33. The Glu318Gly substitution in presenilin 1 is not causally related to Alzheimer disease
34. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1
35. Presenilins interact with Rab11, a small GTPase involved in the regulation of vesicular transport
36. A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43)
37. Association between bleomycin hydrolase and Alzheimer's disease in caucasians
38. Association between angiotensin-converting enzyme and Alzheimer disease
39. BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein
40. Presenilin 1 is actively degraded by the 26S proteasome
41. Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts
42. Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD
43. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease
44. Alzheimer's disease associated presenilin-1 holoprotein and its 18-20 kDa C-tereminal fragment are death substrates for proteases of the caspase family
45. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: Involvement of calcium and oxyradicals
46. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor
47. The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway
48. No genetic effect of alphal-antichymotrypsin in Alzheimer disease
49. Characterization of Alzheimer's beta -secretase protein BACE. A pepsin family member with unusual properties
50. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans
51. No association of alpha-2 macroglobulin gene five-nucleotide deletion with AD in Taiwan Chinese
52. The human FE65 gene: Genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type
53. Isoform-specific interactions of apolipoprotein E with the microtubule- associated protein MAP2c: Implications for Alzheimer's disease
54. ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation
55. Maturation and endosomal targeting of BACE: The Alzheimer's disease {beta}-secretase
56. Identification of a novel aspartic protease (Asp 2) as beta-secretase
57. Presenilin 1 suppresses the function of c-Jun homodimers via interaction with QM/Jif-1
58. Genome-wide analysis of single-nucleotide polymorphisms in human expressed sequences
59. Mutation in codon 713 of the beta amyloid precursor protein gene presenting with schizophrenia
60. APOE*4-associated Alzheimer's disease risk is modified by alpha 1- antichymotrypsin polymorphism
61. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease
62. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
63. A full genome scan for late onset Alzheimer's disease
64. Lack of interactions between amyloid precursor protein and hydrophilic domains of presenilin 1 and 2 using the yeast two hybrid system
65. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease
66. Alpha-2 macroglobulin gene in early- and late-onset Alzheimer disease
67. The alpha2-macroglobulin gene in AD: A population-based study and meta- analysis
68. L.D.L. receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation
69. Alpha-2-macroglobulin intronic polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease
70. Separation of presenilin function in amyloid beta-peptide generation and endoproteolysis of Notch
71. The transcriptional factor LBP-lc/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease
72. A detergent-insoluble membrane compartment contains A beta in vivo
73. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease
74. Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and beta-catenin
75. Assessment of normal and mutant human presenilin and function in Caenorhabditis elegans
76. Facilitation of lin-12-mediated signalling by sel- 12, a Caenorhabditis elegans S182 Alzheimer's disease gene
77. A familial Alzheimer's disease locus on chromosome 1
78. HOP-1, a Caenorhabditis elegans presenilin, appears to be functionally redundant with SEL-12 presenilin and to facililate LIN-12 and GLP-1 signaling
79. Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state
80. Photoactivated gammasecretase inhibitors directed to the active site covalently label presenilin 1
81. Human aspartic acid protease memapsin 2 cleaves the
82. Apolipoprotein E and Alzheimer's disease: Ethnic variation in genotypic risks
83. Neurodegeneration in the central nervous system of apoE-deficient mice
84. The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease
85. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease
86. Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease
87. Tests and estimates of allelic association in complex inheritance
88. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid
89. Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease
90. Genetic association of alpha2-macroglobulin with Alzheimer's disease in a Finnish elderly population
91. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline
92. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro
93. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization
94. Association of interleukin-1 gene polymorphisms with Alzheimer's disease
95. A loss of function mutant of the presenilin homologue sel-12 undergoes abberant endoproteolysis in Caenorhabditis elegans and increased A-beta-42 generation in human cells
96. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease
97. A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease
98. Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bcl-X(L). A potential role in modulating the threshold of cell death
99. Linkage studies in familial Alzheimer disease: Evidence for chromosome 19 linkage
100. Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue
101. A familial case of Alzheimer's disease without tau pathology may be linked with chromosome 3 markers
102. Evidence for a physical interaction between presenilin and Notch
103. Expression studies of the gene encoding the Alzheimer's Disease and Down Syndrome amyloid peptide
104. N-acetyltransferase (NAT2) genotype and susceptibility of sporadic Alzheimer's disease
105. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene
106. Evidence for an Alzheimer disease susceptibilily locus on chromosome 12 and for further locus heterogeneity
107. Screening for PS-1 mutations in a referral based series of Alzheimer's disease cases: 21 Novel mutations
108. Apolipoprotein E and Alzheimer's disease. The tip of the susceptibility iceberg
109. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease
110. Evidence that intramolecular associations between presenilin domains are obligatory for endoproteolytic processing
111. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
112. Alzheimer's presenilin 1 is a putative membrane receptor for rab GDP dissociation inhibitor
113. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
114. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease
115. Presenilin-1 polymorphism and Alzheimer's disease
116. Normal and abnormal biology of the beta-amyloid precursor protein
117. Skeletal and CNS defects in Presenilin-1-deficient mice
118. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant
119. Cloning of a gene bearing missense mutatious in early-onset familial Alzheimer's disease
120. Genetic association between alpha-2 macroglobulin and Japanese sporadic Alzheimer's disease
121. No genetic association between alpha-2 macroglobulin 11000V polymorphism and Japanese sporadic Alzheimer's disease
122. Production of the Alzheimer amyloid beta protein by normal proteolytic processing
123. Alpha2-macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodies
124. Purification and cloning of amyloid precursor protein beta-secretase from human brain
125. A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer's amyloid precursor protein beta-secretase
126. Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations
127. Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE
128. The TDT and other family-based tests for linkage disequilibrium and association
129. Direct interaction of Alzheimer's disease-related presenilin 1 with armadillo protein p0071
130. A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signaling
131. Isoform-specific interactions of apolipoprotein E with microtubule- associated protein tau: Implications for Alzheimer disease
132. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of lype type 4 allele in late-onset familial Alzheimer disease
133. Binding of human apolipoprotein E to synthetic amyloid bela peptide: Isoform-specific effects and implications for late-onset Alzheimer disease
134. Presenilin is required for activity and nuclear access of Notch in Drosophila
135. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants
136. Amyloid-beta-protein isoforms in brain of subjects with PSI-linked, beta APP-linked and sporadic Alzheimer disease
137. Molecular genetics of Alzheimer's disease: The role of beta-amyloid and the presenilins
138. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics
139. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus
140. A haplotype-based 'haplotype relative risk' approach to detecting allelic associations
141. Transcriptional regulation of Alzheimer's disease genes: Implications for susceptibility
142. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo
143. Stable association of presenilin derivatives and absence of presenilin interactions with APP
144. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: Independent risk and linkage disequilibrium with the known APOE polymorphism
145. Beta-Secretase Cleavage of Alzheimer's Amytoid Precursor Protein by the Transmembrane Aspartic Protease BACE
146. Interfering with apoptosis: Ca(2+)-binding protein ALG-2 and Alzheimer's disease gene ALG-3
147. No association between the alpha-2 macroglobulin 11000V polymorphism and Alzheimer's disease
148. Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and beta-amyloid precursor protein
149. Reverse genetic analysis of Caenorhabditis elegans presenilins reveals redundant but unequal roles for sel-12 and hop-1 in Notch-pathway signaling
150. Presenilin is required for proper morphology and function of neurons in C. elegans
151. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity
152. Participation of presenilin 2 in apoptosis: Enhanced basal activity conferred by an Alzheimer mutation
153. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm
154. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease
155. Interaction between amyloid precursor protein and presenilins in mammalian cells: Implications for the pathogenesis of Alzheimer disease
156. Higher avidity binding of apolipoprotein (E-AII) complex than of apolipoprotein E monomer to beta-amyloid
157. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity
158. Mechanisms of neuronal degeneration in Alzheimer's disease
159. Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants
160. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin
161. Mutation of conserved aspartates affects maturation of both aspartate mutant and endogenous presenilin 1 and presenilin 2 complexes
162. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing
163. Mutation of the conserved N-terminal cysteine (Cys92) of human presenilin causes increased Abeta42 secretion in mammalian cells by impaired Notch/Lin12 signalling in C. Elegans embryos
164. Interaction of presenilins with the filamin family of actin-binding proteins
165. Presenilin 1 interaction in the brain with a novel member of the Armadillo family
166. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12
167. Alpha-2 macroglobulin is genetically associated with Alzheimer disease
168. An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease
169. Susceptibility locus for Alzheimer's disease on chromosome 10
170. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees